|
| Value |
|
| Gender, (%) | |
| Female | 570 (53.7) |
| Male | 491 (46.3) |
| Age, | |
| Number of patients by age group, (%) | |
| 65 to 69 years | 246 (23.2) |
| 70 to 74 years | 284 (26.8) |
| 75 to 79 years | 233 (22.0) |
| >80 years | 298 (28.1) |
| Admission department, (%) | |
| Gynecology | 33 (3.1) |
| Hepatobiliary | 399 (37.6) |
| Orthopedics | 154 (14.5) |
| Endocrine breast | 8 (0.8) |
| Neurosurgery | 13 (1.2) |
| Vascular | 454 (42.8) |
| ATC codes of drugs causing DRPs | Number of drugs (%) |
| A: alimentary tract and metabolism | 337 (31.8) |
| A02 drugs for acid-related disorders | 17 (1.6) |
| A03 drugs for functional gastrointestinal disorders | 1 (0.1) |
| A04 antiemetics and antinauseants | 5 (0.5) |
| A05 bile and liver therapy | 41 (3.9) |
| A10 drugs used in diabetes | 7 (0.7) |
| A12 mineral supplements | 38 (3.6) |
| A16 other alimentary tract and metabolism products | 228 (21.5) |
| B: blood and blood-forming organs | 238 (22.4) |
| B01 antithrombotic agents | 30 (2.8) |
| B02 antihemorrhagics | 88 (8.3) |
| B03 antianemic preparations | 43 (4.1) |
| B05 blood substitutes and perfusion solutions | 77 (7.3) |
| C: cardiovascular system | 126 (11.9) |
| C01 cardiac therapy | 1 (0.1) |
| C02 antihypertensive | 2 (0.2) |
| C04 peripheral vasodilators | 109 (10.3) |
| C05 vasoprotectives | 13 (1.2) |
| C10 lipid-modifying agents | 1 (0.1) |
| D: dermatologicals | 1 (0.1) |
| D04 antipruritics, incl. antihistamines and anesthetics | 1 (0.1) |
| G: genitourinary system and sex hormones | 1 (0.1) |
| G04 urologicals | 1 (0.1) |
| H: systemic hormonal preparations excl. sex hormones and insulins | 7 (0.7) |
| H02 corticosteroids for systemic use | 7 (0.7) |
| J: anti-infectives for systemic use | 249 (23.5) |
| J01 antibacterials for systemic use | 234 (22.1) |
| J04 antimycobacterials | 8 (0.8) |
| J05 antivirals for systemic | 7 (0.7) |
| L: antineoplasic and immunomodulating agents | 6 (0.6) |
| L03 imostimulants | 6 (0.6) |
| M: musculoskeletal system | 6 (0.6) |
| M01 anti-inflammatory and antirheumatic products | 2 (0.2) |
| M05 drugs for treatment of bone diseases | 4 (0.4) |
| N: nervous system | 50 (4.7) |
| N02 analgesics | 5 (0.5) |
| N05 psycholeptics | 4 (0.4) |
| N07 other nervous system drugs | 41 (3.9) |
| R: respiratory system | 26 (2.5) |
| R03 drugs for obstructive airway diseases | 26 (2.5) |
| V: various | 14 (1.3) |
| V03 all other therapeutic products | 5 (0.5) |
| V06 general nutrients | 6 (0.6) |
| V08 contrast media | 3 (0.3) |
|
